Showing results (121-130 of 147) with videos related to
Sort By:
Pageof 15
Brain Communications|July 13, 2026
Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled trialThomas Williams, Nicholas Magill, Nevin A John, et al.Journal of Neurology|May 21, 2026
Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx studyFrancesco Romanò, Paola Valsasina, Matteo Albergoni, et al.Neurorehabilitation and Neural Repair|March 1, 2024
Prevalence and Associated Clinical Characteristics of Walking-Related Motor, Cognitive, and Fatigability in Progressive Multiple Sclerosis: Baseline Results From the CogEx StudyCintia Ramari, Mieke D'hooge, Ulrik Dalgas, et al.JAMA Neurology|October 18, 2016
Analysis of Mutations in AARS2 in a Series of CSF1R-Negative Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented GliaDavid S Lynch, Wei Jia Zhang, Rahul Lakshmanan, et al.Journal of Neurology|November 27, 2022
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosisPaolo Preziosa, Maria A Rocca, Elisabetta Pagani, et al.Journal of Neurology|May 31, 2018
Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging studyIan Marshall, Michael J Thrippleton, Mark E Bastin, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2024
Cognitive rehabilitation effects on grey matter volume and Go-NoGo activity in progressive multiple sclerosis: results from the CogEx trialMaria A Rocca, Paola Valsasina, Francesco Romanò, et al.Brain Communications|May 6, 2024
CSF neurofilament light chain profiling and quantitation in neurological diseasesClaire A Leckey, John B Coulton, Tatiana A Giovannucci, et al.Neuroimage. Reports|September 27, 2024
Investigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trialThomas Williams, Nevin John, Alberto Calvi, et al.BMJ Open|September 1, 2018
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosisPeter Connick, Floriana De Angelis, Richard A Parker, et al.Pageof 15